Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 382.00
Bid: 374.00
Ask: 384.00
Change: 12.00 (3.24%)
Spread: 10.00 (2.674%)
Open: 382.00
High: 382.00
Low: 382.00
Prev. Close: 370.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

3 Nov 2009 07:00

RNS Number : 8204B
Microgen PLC
03 November 2009
 



microgen

www.microgen.com

3 November 2009

INTERIM MANAGEMENT STATEMENT

Microgen plc ('Microgen' or 'Group'announces its Interim Management Statement covering the period from 1 July 2009 to the date of this announcement. Microgen announced its interim results for the period ending 30 June 2009 on 21 July 2009.

The Group's financial results for the three months ended 30 September 2009 are ahead of the Group's annual plan. The Group's balance sheet remains strong, with £17.5 million of cash (30 June 2009: £15.2 million) and net funds of £15.2 million (30 June 2009: £12.8 million) at 30 September 2009, including proceeds of approximately £0.8 million from the disposal of 54% of the Group's shareholding in Scisys plc.

In a separate announcement this morning, Microgen has announced the proposed disposal of the Billing Services Division ("BSD") to a subsidiary of Swiss Post for a cash consideration of £7.5 million before expenses. Subject to shareholder approval of the proposed disposal, a special dividend of 4.0 pence per share will be paid. As the core business of Microgen has evolved to be based around software and associated consultancy, BSD has become increasingly non-core with little strategic overlap with the other Microgen business activities. With the success of Microgen Aptitude, the Board considers that it is now the right time to dispose of the BSD operations. If approved by shareholders, the proposed disposal will produce an exceptional profit in the current financial year, which will be partially offset by a revaluation of the Group's freehold property in line with the decline in the commercial property market. Further details on the proposed disposal and the special dividend are provided in the separate announcement.

In the third quarter, Microgen Aptitude Solutions Division ("MASD"reported an operating profit, ahead of the Board's expectations. In the period, MASD won a major new banking customer in Asia for Microgen Accounting Hub and Microgen Aptitude. This project is now underway and additional opportunities for further Microgen Aptitude based products in this account are anticipated in the future. The two major USA prospects referred to in the trading update released on 7 July 2009 have now completed their design phase, although one of these prospects is likely to be delayed until the new year due to a change in FASB accounting rules. Even with this delay, the performance of the MASD business is ahead of the Group's annual plan and MASD now anticipates reporting an operating profit for the year as a whole. (For reference, MASD reported an operating loss of £0.6 million for the first half of 2009 and an operating loss of £2.4 million for 2008). Furthermore, with the currently contracted/scheduled business and the prospect opportunities, the Board anticipates a strong performance in 2010, which should materially compensate for the reduction in profit contribution associated with the disposal of BSD.

As reported at the interim results, the Financial Systems Division ("FSD") has experienced some effects of the economic climate, but the high levels of recurring revenue and strong profitability of the business provide resilience to the economic instability. This strong foundation is derived from the Group's emphasis on multi-year annual licensing. As a result, despite the market environment, the FSD strong operating margins and cash flow have been sustained. The Board has also reviewed the product portfolio within FSD and have decided to end-of-life a number of smaller product lines, with revenue in the first half of 2009 in the order of £0.3 million.

In summary, the Board is pleased that the Group is on track to exceed the Board's current expectations, which have, despite the economic environment, already been increased this year. The success in 2009 also provides an excellent platform for 2010 and the Group's strong balance sheet, further enhanced by the proposed disposal of BSD, provides the Board with the resources to consider acquisition opportunities if appropriate.

Contacts

Martyn Ratcliffe, Chairman

01252-772300

David Sherriff, Chief Operating Officer

Philip Wood, Group Finance Director

Giles Sanderson, Financial Dynamics

Haya Chelhot, Financial Dynamics

020-7831-3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBJBMTMMBMMJL
Date   Source Headline
9th Jun 20157:00 amRNSAcquisition
18th May 20159:58 amRNSResult of AGM
18th May 20157:00 amRNSAGM Trading Update
29th Apr 201512:26 pmRNSHolding(s) in Company
30th Mar 20155:49 pmRNSBlocklisting Interim Review
19th Mar 20157:00 amRNSReturn of Value and Listing of New Ordinary Shares
18th Mar 201511:23 amRNSResults of General Meeting
6th Mar 201512:22 pmRNSHolding(s) in Company
26th Feb 20153:39 pmRNSHolding(s) in Company
25th Feb 20152:26 pmRNS2014 Final Dividend
25th Feb 20157:02 amRNSReturn of Value
25th Feb 20157:01 amRNSPreliminary Results
28th Jan 20152:02 pmRNSHolding(s) in Company
23rd Jan 20151:17 pmRNSHolding(s) in Company
23rd Jan 20157:00 amRNSTrading Update
21st Jan 201512:14 pmRNSDirector Declaration
5th Jan 20157:00 amRNSBlocklisting Interim Review
5th Dec 20147:00 amRNSAcquisition
3rd Nov 20147:00 amRNSTotal Voting Rights
30th Oct 20147:00 amRNSInterim Management Statement
7th Oct 20142:28 pmRNSAdditional Listing
30th Sep 20142:47 pmRNSBlocklisting Interim Review
15th Sep 20145:04 pmRNSHolding(s) in Company
1st Sep 20147:00 amRNSTotal Voting Rights
21st Jul 20147:00 amRNSInterim Results
14th Jul 20143:00 pmRNSNotice of Results
1st Jul 201412:11 pmRNSBlocklisting Interim Review
20th Jun 20148:10 amRNSDirector Declaration
17th Jun 20147:00 amRNSStatement regarding Elektron Technology plc
11th Jun 20149:34 amPRNForm 8 (OPD) Microgen plc
5th Jun 20142:20 pmRNSForm 8.3 - Microgen Plc
5th Jun 201412:13 pmRNSForm 8.3 - Microgen PLC
2nd Jun 20145:33 pmRNSForm 8 (OPD) Microgen plc
2nd Jun 201412:35 pmRNSForm 8.3 - [Microgen Plc]
2nd Jun 201410:50 amRNSTotal Voting Rights
30th May 201410:23 amBUSForm 8.3 - Microgen Plc
29th May 201410:08 amRNSRule 8.3 opening position disclosure
27th May 20142:39 pmPRNForm 8.3 - Microgen plc
27th May 20142:10 pmRNSStatement re Elektron Technology Plc
27th May 201411:44 amRNSForm 8.3 - Microgen Plc
23rd May 20145:22 pmRNSForm 8.3 - Microgen plc
23rd May 201410:22 amRNSForm 8.3 - Microgen Plc
21st May 20143:29 pmRNSForm 8.3 - [Microgen plc]
21st May 20143:04 pmRNSForm 8.3 - Microgen Plc
21st May 20142:13 pmRNSForm 8.3 - MICROGEN PLC
21st May 20141:10 pmRNSForm 8.3 - Microgen Plc
21st May 201411:48 amBUSForm 8.3 - Microgen Plc
21st May 201411:46 amRNSForm 8.3 - [MICROGEN PLC]
21st May 201411:21 amRNSForm 8.3 - MICROGEN ORD GBP0.05
21st May 20149:00 amRNSResponse to Microgen

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.